APT Medical Inc
SSE:688617
| US |
|
Cleveland-Cliffs Inc
NYSE:CLF
|
Metals & Mining
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
| KY |
|
StoneCo Ltd
NASDAQ:STNE
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
231.673
439
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Cleveland-Cliffs Inc
NYSE:CLF
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
|
|
StoneCo Ltd
NASDAQ:STNE
|
KY |
This alert will be permanently deleted.
APT Medical Inc
Cash & Cash Equivalents
APT Medical Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
APT Medical Inc
SSE:688617
|
Cash & Cash Equivalents
¥1.3B
|
CAGR 3-Years
120%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash & Cash Equivalents
¥6.5B
|
CAGR 3-Years
35%
|
CAGR 5-Years
57%
|
CAGR 10-Years
36%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash & Cash Equivalents
¥20.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Cash & Cash Equivalents
¥1.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash & Cash Equivalents
¥3.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash & Cash Equivalents
¥7.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
APT Medical Inc
Glance View
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.
See Also
What is APT Medical Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.3B
CNY
Based on the financial report for Dec 31, 2023, APT Medical Inc's Cash & Cash Equivalents amounts to 1.3B CNY.
What is APT Medical Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
70%
Over the last year, the Cash & Cash Equivalents growth was 413%. The average annual Cash & Cash Equivalents growth rates for APT Medical Inc have been 120% over the past three years , 70% over the past five years .
You don't have any saved screeners yet
